Trial Site Detail

 

Drug:
Regorafenib (BAY 73-4506)
Trial:
Phase II Study of Continuous Dosing of Regorafenib in Patients With Gastrointestinal Stromal Tumors (GISTs) After Failure of Imatinib and Sunitinib
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Asan Medical center

     
Seoul , Songpa-gu 138-736
Republic of Korea

 

Principal Investigator:
 Yoon-Koo Kang, MD, Phd
Contact:
 Yoon-Koo Kang, MD, PhD 82-2-3010-2043 ykk@amc.seoul.kr
Activation Status of this Site:
 Closed
Notes about this Site:
Asan Medical center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.